Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“I worry for my patients,” says a researcher at the Chicago CORE center. The pause also affects trials for cancer, COVID and mpox.
A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.
A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.
Cancer patients undergoing treatment and those with suppressed immune systems eye the future—and the COVID pandemic’s wane—warily.
“Over 40% of the vulnerable population in the U.S. lives within 5 miles of a CVS Pharmacy location, so we have a chance to engage them.”
NIH-supported research will track effects of coronavirus infection on children over three years.
Certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed.
Eventual vaccination of children will be crucial to subduing the COVID virus, but pediatricians are split on how fast to move toward that.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Some experts want to hold out for a more optimal vaccine. Others believe accepting the best possible vaccine sooner than later is ideal.
None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.
The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.